Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer’s disease immunotherapeutics
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer’s disease immunotherapeutics ; volume:6 ; number:4 ; day:9 ; month:7 ; year:2014 ; pages:1-15 ; date:8.2014
Alzheimer's research & therapy ; 6, Heft 4 (9.7.2014), 1-15, 8.2014
- Creator
-
Goure, William F.
- Contributor
-
Krafft, Grant A.
Jerecic, Jasna
Hefti, Franz
SpringerLink (Online service)
- DOI
-
10.1186/alzrt272
- URN
-
urn:nbn:de:1111-2016073131938
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Goure, William F.
- Krafft, Grant A.
- Jerecic, Jasna
- Hefti, Franz
- SpringerLink (Online service)
Other Objects (12)
Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas
Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease
Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer’s Disease
Amyloid-beta uptake by blood monocytes is reduced with ageing and Alzheimer’s disease
Pathological changes induced by Alzheimer’s brain inoculation in amyloid-beta plaque-bearing mice
Rolle des alpha2-Makroglobulin beim proteolytischen Abbau des Alzheimer Amyloid-beta
Molekulare Pathomechanismen Phosphorylierter Amyloid-beta (Aβ)-peptide in der Alzheimer-Krankheit
Quantitative characterization of amyloid-beta interaction with artificial compounds designed for Alzheimer´s disease therapy
Noncanonical regulation of imprinted gene Igf2 by amyloid-beta 1–42 in Alzheimer’s disease
Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study
Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas
Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease
Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer’s Disease
Amyloid-beta uptake by blood monocytes is reduced with ageing and Alzheimer’s disease
Pathological changes induced by Alzheimer’s brain inoculation in amyloid-beta plaque-bearing mice
Rolle des alpha2-Makroglobulin beim proteolytischen Abbau des Alzheimer Amyloid-beta
Molekulare Pathomechanismen Phosphorylierter Amyloid-beta (Aβ)-peptide in der Alzheimer-Krankheit
Quantitative characterization of amyloid-beta interaction with artificial compounds designed for Alzheimer´s disease therapy
Noncanonical regulation of imprinted gene Igf2 by amyloid-beta 1–42 in Alzheimer’s disease
Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study
Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas
Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease
Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
Astroglial Responses to Amyloid-Beta Progression in a Mouse Model of Alzheimer’s Disease
Amyloid-beta uptake by blood monocytes is reduced with ageing and Alzheimer’s disease
Pathological changes induced by Alzheimer’s brain inoculation in amyloid-beta plaque-bearing mice
Rolle des alpha2-Makroglobulin beim proteolytischen Abbau des Alzheimer Amyloid-beta
Molekulare Pathomechanismen Phosphorylierter Amyloid-beta (Aβ)-peptide in der Alzheimer-Krankheit
Quantitative characterization of amyloid-beta interaction with artificial compounds designed for Alzheimer´s disease therapy
Noncanonical regulation of imprinted gene Igf2 by amyloid-beta 1–42 in Alzheimer’s disease